DAAP's AI-driven Patient Discovery module used longitudinal patient RWD to learn the characteristics of undiagnosed and relapsing patients, then predicted both future patient eligibility and the ideal time to engage their treating HCP with brand information.
Discovered brand-qualified patients earlier in the disease journey and predicted when patients were experiencing relapse symptoms.